We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGCLA.L Regulatory News (GCLA)

  • There is currently no data for GCLA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

29 Aug 2017 17:25

RNS Number : 2267P
Grupo Clarin S.A.
29 August 2017
 

This form is intended for use by an issuer to make a RIS notification required by DR 3.1.4R(1).

 

(1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

 

(2) An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8,13, 14, 16, 23 and 24.

 

(3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

 

(4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.

 

Please complete all relevant boxes should in block capital letters.

 

1. Name of the issuer

 

GRUPO CLARÍN S.A.

....................................

 

2. State whether the notification relates to (i) a transaction notified in accordance with DR 3.1.4R(1)(a); or (ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as extended by section 328) of the Companies Act 1985; or

(iii) both (i) and (ii):

 

....................................

 

3. Name of person discharging managerial responsibilities/director

 

SEBASTIAN BARDENGO (MANAGER and ALTERNATE DIRECTOR)

 

....................................

 

4. State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

 

....................................

 

5. Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

 

3 ABOVE

....................................

 

6. Description of shares (including class), debentures or derivatives or financial instruments relating to shares

 

- CLASS B COMMON SHARES OF THE COMPANY, WITH NOMINAL VALUE OF ONE (1) ARGENTINE PESO PER SHARE

....................................

 

7. Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

N/A

....................................

 

8. State the nature of the transaction

 

- ACQUISITION OF CLASS B COMMON SHARES

 

 

 

9. Number of shares, debentures or financial instruments relating to shares acquired

 

 

SEBASTIAN BARDENGO Number of shares: 1,360 Class B Common Shares

 

 

....................................

 

10. Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

 

SEBASTIAN BARDENGO Percentage: 0.0007% of CLASS B COMMON SHARES

 

....................................

 

11. Number of shares, debentures or financial instruments relating to shares disposed

N/A

....................................

 

12. Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

N/A

....................................

 

 

13. Price per share or value of transaction

 

 

SEBASTIAN BARDENGO: 1,360 shares at AR$ 257.0 per share

 

 

 

 

14. Date and place of transaction

 

 

SEBASTIAN BARDENGO: 1,360 SHARES on 23 August 2017, Buenos Aires

....................................

 

15. Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

 

SEBASTIAN BARDENGO:

7,820 COMMON SHARES (0.0027% OF OUTSTANDING CAPITAL STOCK)

 

 

 

....................................

 

16. Date issuer informed of transaction

 

....................................

 

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes

17. Date of grant

....................................

18. Period during which or date on which it can be exercised

....................................

19. Total amount paid (if any) for grant of the option

....................................

20. Description of shares or debentures involved (class and number)

....................................

21. Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

....................................

22. Total number of shares or debentures over which options held following notification

....................................

 

23. Any additional information

 

N/A

....................................

 

24. Name of contact and telephone number for queries

 

IN BUENOS AIRES:

AGUSTIN MEDINA MANSON/PATRICIO GENTILE

GRUPO CLARÍN

EMAIL: INVESTORS@GRUPOCLARIN.COM

 

IN LONDON:

ALEX MONEY

JASFORD IR

TEL: +44 20 3289 5300

EMAIL: ALEXM@JASFORD.COM 

 

IN NEW YORK:

MELANIE CARPENTER

I-ADVIZE CORPORATE COMMUNICATIONS

TEL: +1 212 406 3692

EMAIL: CLARIN@I-ADVIZE.COM

....................................

Name and signature of duly authorised officer of issuer responsible for making notification

 

AGUSTIN MEDINA MANSON, Responsible for Market Relations, Grupo Clarín S.A.

....................................

Date of notification

August 29, 2017

....................................

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHSEDFMUFWSEEA
Date   Source Headline
23rd Nov 20237:00 amRNSGrupo Clarín Delisting of Global Depositary Shares
23rd Nov 20237:00 amRNSExpected Delisting of Global Depositary Shares
13th Nov 20237:00 amRNS3rd Quarter and 9 Month Results
25th Oct 20233:24 pmRNSBuy out of minority shareholders in subsidiary
9th Oct 202312:57 pmRNSFormer employee files claim
9th Oct 202312:56 pmRNSCompany makes equity contribution
7th Sep 20235:35 pmRNSConsumer association files claim
14th Aug 20237:53 amRNSHalf-year Report
14th Jun 20234:06 pmRNSLeave of Absence
9th Jun 20238:57 amRNSLeave of Absence
15th May 20237:00 amRNS1st Quarter Results
2nd May 20237:04 amRNSAnnual Financial Report
2nd May 20237:00 amRNSAudit Committee
28th Apr 20236:25 pmRNSDirectorate Change
28th Apr 20236:19 pmRNSGCSA Holds Shareholders' Meeting
14th Apr 20237:00 amRNSResponse to Shareholder Information Request
12th Apr 20237:00 amRNSResponse to Shareholder Information Request
22nd Mar 20234:54 pmRNSReplacement: Annual Shareholders’ Meeting
21st Mar 20237:25 amRNSAnnual Shareholders’ Meeting
14th Mar 202311:20 amRNSCorrection: Leave of Absence
14th Mar 20237:00 amRNSLeave of Absence
13th Mar 20237:00 amRNSFull Year and Last Quarter 2022 Results
6th Mar 20237:00 amRNSWebcast to discuss 4Q and FY 2022 results
15th Feb 20239:19 amRNSMinority shareholder files claim
16th Jan 20236:15 pmRNSSecretary of Trade imposes Fine on Subsidiary
28th Dec 20227:00 amRNSDirectorate Change
28th Dec 20227:00 amRNSResult of Meeting
28th Dec 20227:00 amRNSResult of Meeting
7th Dec 20229:00 amRNSResult of Meeting
7th Dec 20229:00 amRNSLeave of Absence
2nd Dec 20221:42 pmRNSDirectorate Change
14th Nov 20227:25 amRNSNine months and Third Quarter 2022 Results
31st Oct 20228:07 amRNSNotice of Results
27th Oct 20227:00 amRNSNotice to Global Depository Receipt Holders
9th Sep 20226:20 pmRNSAGM Statement
6th Sep 20221:07 pmRNSAcquisition
26th Aug 20227:00 amRNSLeave of Absence
23rd Aug 20227:00 amRNSResponse to Shareholder Information Request
12th Aug 20227:00 amRNSFirst Half and Second Quarter 2022 Results
3rd Aug 20226:22 pmRNSGCLA Calls Extraordinary Shareholders’ Meeting
25th Jul 20226:18 pmRNSNotice of Results
14th Jul 20221:11 pmRNSGuarantee in favour of Tele Red Imagen S.A
6th Jul 20229:07 amRNSCourt of Appeals Nullifies Resolution
17th Jun 20227:00 amRNSResponse to Shareholder Information Request
16th Jun 20224:20 pmRNSAppellate Decision in Pol-Ka Dispute
12th May 20227:00 amRNS1st Quarter 2022 Results
3rd May 20227:00 amRNSWebcast presentation to discuss 1Q 2022 results
20th Apr 20228:46 amRNSMembership of Audit Committee
19th Apr 20227:00 amRNSDirectorate Change
19th Apr 20227:00 amRNSGrupo Clarin holds Shareholders' Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.